Elodie Gautier‐Veyret

Variability of Voriconazole Plasma Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Cytochrome P450 Polymorphisms and Comedications on Initial and Subsequent Trough Levels

Elodie Gautier‐Veyret, Xavier Fonrose, Julia Tonini et al. · Antimicrobial Agents and Chemotherapy · 2015 · 64 citations · Full text

Trough Concentrations, Transplantation Medicine, Pharmacotherapy +16

A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease

Théo Willeman, Jean‐François Jourdil, Elodie Gautier‐Veyret et al. · Analytica Chimica Acta · 2019 · 64 citations · Full text

Autoimmune Disease, Therapeutic Monoclonal Antibodies, Bioanalysis +9

Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis

Elodie Gautier‐Veyret, Claire Arnaud, Magnus Bäck et al. · European Respiratory Journal · 2012 · 54 citations · Full text

Vascular Disease, Lipid Peroxidation, Intermittent Hypoxia Exposure +18

Inflammation is a potential risk factor of voriconazole overdose in hematological patients

Elodie Gautier‐Veyret, Aurélie Truffot, Sébastien Bailly et al. · Fundamental and Clinical Pharmacology · 2018 · 39 citations

Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?

Jean‐François Jourdil, Dorothée Lebert, Elodie Gautier‐Veyret et al. · Analytical and Bioanalytical Chemistry · 2016 · 35 citations

Translational Medicine, Gas Chromatography, Medicine +13